Would-Be FDA 'Maturity Model' Pilot Might Reward Firms With Delayed Inspections

"Mature" device manufacturers could put off an FDA inspection for a few years if they independently verify that they have robust quality metrics in place under a potential pilot program, CDRH's new compliance head says. The pilot would be part of FDA's plan under its Case for Quality to use a maturity model to prioritize facility inspections.

More from Archive

More from Medtech Insight